Menlo Therapeutics Announces Results from a Phase 2 Trial of Serlopitant for Pruritus Associated with Atopic Dermatitis Pharmaceutical Investing
Inspire Medical Systems Announces Filing of Registration Statement for Proposed Initial Public Offering Medical Device Investing
Relevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through European Expansion of Bioganix Medical Device Investing
Isodiol International Inc. Announces Letter of Intent to Supply 99.5%+ Pharma-Grade Cannabidiol to Agrima Botanicals Cannabis Investing News
Xanthic Biopharma Inc. Receives Conditional Listing Approval from the Canadian Securities Exchange Cannabis Investing News
EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 Pharmaceutical Investing
Aclaris Therapeutics Partners with Cipher Pharmaceuticals to seek regulatory approval and commercialize A-101 40% topical solution Pharmaceutical Investing
